ORC Expert Advisory Services ORC International

  home    |    find an expert    |    request an expert    |    join our network    |    about us     expert login  
Expert Consulting and Expert Witness Services
  
  search tips 
Share this page:  Send to LinkedIn Send to Facebook Tweet This Email Print

 Expert  731256

Expert in Molecular Psychiatry and Neuroscience, Neuropharmacology, Cancer Immunotherapy


Available for your Consulting and Expert Witness Needs

United Kingdom
Education Work History Career AccomplishmentsPublicationsConsulting Services Expert Witness Market Research

Summary of Expertise:

Listed with other top experts in: 

Expert has combined his extensive expertise in molecular biology, immunology, molecular neuroscience and psychiatry, and cancer biology to develop a new avenue in the discovery of suitable molecular targets for complex treatment of neurodevelopmental disorders (e.g. ADHD). The new treatment strategies are designed to avoid adverse effects while taking care not only for managing the symptoms of the disorders but to result in their cure.

At the moment, some novel and exciting unpublished strategies for treatment of ADHD are considered by Expert. He obtained in vitro data supporting the idea that such treatment with naturally existing molecules will result in better development of children's brain and possibly take care for removing the insomnia from which ADHD patients suffer. Expert is particularly interested in pursuing this new treatment strategy in animal models and in patients.

He has also consulted on applicability of different nanoparticles carriers of drugs in neorodevelopmental and other neurological disorders. This is a very important issue because in general all drugs and their carriers are tested for toxicity while not taking good care for their potential adverse effects by a complex assessment of physiological alterations that might occur.

He has combined his extensive expertise in molecular biology, immunology, molecular neuroscience and cancer biology to develop a new avenue in the discovery of suitable molecular targets for treatment of different tumour types which result specifically in killing the cancer cells while not having significant effect on non-malignant ones. These strategies have been tested both in vitro and in vivo showing a great promise. Some of the designed peptides have been filed for a patent application.

 Highly creative science leader with over 20 year experience in life and pharmaceutical sciences with particular emphasis on protein chemistry, immunotherapeutics, neuroscience/molecular psychiatry, working for organisations in Europe, North America and Middle East, focused on innovation and development of new therapeutics.  Outstanding manager with unique profile, combining strong technical and teaching/training expertise, innovatively leading multi-cultural teams to deliver growth solutions.  A proven track record in discovery of new therapeutic targets and development of new treatments.  Influencing and growing life science publishing business and implementing a consumer-focused approach.

CORE QUALIFICATIONS & STRENGTHS

 Effective and innovative project and people management  Strategic agility, project planning and budgeting  Product development: discovery of new therapeutic targets and drug development KEY ACHIEVEMENTS PROJECT MANAGEMENT Led and successfully completed a number of projects focused on:  Design and assessment of oral formulations of therapeutic antibodies for treatment of infections and disorders of the gastrointestinal tract  Signalling/molecular mechanisms underlying inflammatory responses in neuropsychiatric disorders and identification of suitable therapeutic targets for drug development  Design of peptide adjuvants for targeted sensitisation of certain tumours to immunoclearance  Currently organizing clinical trial

 • 

C5a peptide

 • 

neuropharmacology

 • 

neurobiology

 • 

neuropsychopharmacology

 • 

neurotoxicology

 • 

active pharmaceutical ingredient

 • 

cancer immunotherapy


Show Secondary and Basic Areas of Expertise

Education:
Year   Degree   Subject   Institution  
1999   PhD   Molecular Cell Biology   Institute of Molecular Biology, Bulgarian Academy of Sciences  
1990   MSc   Biotechnology   Faculty of Biology, Sofia University, Bulgaria  
1989   BSC   Biotechnology   Faculty of Biology, Sofia University, Bulgaria  

Work History:
Years   Employer   Department   Title   Responsibilities

2012 to

 

Expert's Firm

 


 

Director

 

He is responsible for the general running of the company, provides editorial support for scientific journals and design of new formulations for skin care products.

2010 to

 

Expert's Firm

 


 

Editor-in-Chief

 

Responsible for identifying suitable topics for volumes of the Advances in Protein Chemistry and Structural Biology in order to increase the reputation and sales of this periodical, assessing and editing contributions to the journal.

2011 to 2012

 

Rostock University

 


 

Visiting Consultant

 

Consultations on interrelationship between complement system and clock genes.

2010 to 2013

 

College of Medicine, Swansea University

 

Neuropsychopharmacology

 

Lecturer

 

Responsible for managing research projects in molecular psychiatry and psychopharmacology, teaching students, supervising academic related staff, undergraduate and postgraduate students working in the laboratory.

2007 to 2009

 

Cardiff University

 

School of Medicine

 

MRC New Investigator Award

 

Identified molecular mechanisms that regulate resistance of brain tumors to immuno- and chemotherapy and designed therapeutic peptides for their sensitisation to clearance by immune system.

2003 to 2007

 

Cardiff University

 

School of Medicine

 

Research Fellow

 

Discovered novel roles of CD59 in immunotherapy.

1999 to 2003

 

London Research Institute

 

Human Cytogenetics Laboratory, Cancer Research UK

 

Research Fellow

 

Human Cytogenetics Laboratory, Cancer Research UK

Discovered new mechanisms regulating the accumulation of amyloid plaques and control of expression of the Major Histocompatibility Complex in human.

1991 to 1999

 

Bulgarian Academy of Sciences

 

Cell Proliferation and Differentiation Laboratory, Institute of Molecular Biology

 

Research Associate

 

Revealed new mechanisms involved in the dynamic of the genome during cell cycle and nuclear compartmentalisation.


Career Accomplishments:
Associations/Societies

- Member of the New York Academy of Sciences - Member of the Network of Healthcare Advisors - Member of the International Complement Society

Professional Appointments

TECHNICAL EXPERTISE  Cell cultures, including primary and stem cells  Cytotoxicity and immunocytotoxicity assays  ELISA  Design of oral and i.v. formulations of immunotherapeutics  DNA/RNA extraction and manipulation  Design and manipulation of recombinant nucleic acids  PCR/qPCR  Biological characterisation of nanoparticles for drug delivery  Epigenetics  Molecular cloning and transfection  Protein expression, purification and characterisation of recombinant and native proteins  Protein-DNA interactions (Chromatin Immunoprecipitation)  Phage-display library for selection of therapeutic peptides and identification of receptors  Design of therapeutic peptides/proteins for immunotherapy  Blood cells purification, stimulation and analysis  Flow cytometry  Immunocytochemistry and immunohistochemistry  Fluorescent in situ hybridisation

Awards/Recognition

Medical Research Council UK, New Investigator Award


Publications:
Publications and Patents Summary

Published over 60 peer-reviewed articles in well-respected and highly reputable journals plus several invited talks and plenary talks and book chapter. Filed one patent application.

Selected Publications and Publishers  
 - Atten Defic Hyperact Disord/Springer  
 - Molecular Psychiatry/Nature Publishing Group  
 - PNAS/PNAS  
 - World J Biol Psychiatry/Informa Healthcare  
 - Nucleic Acids Res/Oxford University Press  

Government Experience:
Years   Agency   Role   Description
2011 to 2011   Medical Research Council, UK   Grant reviewer   He served as a grant reviewer.
2013 to 2013   Agency for Health Quality and Assessment of Catalonia (AHQAC), Barcelona, Spain   Grant reviewer   He served as a reviewer on three grant applications.

Consulting Services:
Selected Consulting Examples:
  • Consulted on interrelationship between complement system and clock genes in ADHD as a strategy for treatment of ADHD patients.
  • He consulted on biomarkers for the response to drug treatment of major depression, signalling/molecular mechanisms underlying responses in major depression and identification of suitable therapeutic targets for drug development.
  • Consulted on different nanoparticles designed as drug carriers in their applicability for treatment of psychiatric disorders without compromising neurogenesis and neurodevelopment.
  • Consulted on methods employed in pharmaceutical and cosmetic industries, and academic research for development of robotised testing platforms.
  • Consulting on continuous increase in reputation and sales of periodicals.
Click the green button above to contact Expert for a free initial screening call regarding your expert consulting needs.  Expert is available for consulting to corporate, legal and government clients.  Remember, your initial screening call to speak with Expert is free.

Expert Witness:
Expert Witness Experience Summary:
BUSINESS DEVELOPMENT AND CONSULTING EXPERIENCE  Developed successful projects for a new private molecular psychiatry laboratory for a client in Kuwait  Improved the reputation and sales of Advances in Protein Chemistry and Structural Biology, Elsevier, New York  Reviewed grants for the Medical Research Council UK, Alzheimer's Society UK and the Agency for Health Quality and Assessment of Catalonia (AHQAC), Barcelona, Spain  Consulted on suitability of different nanoparticles designed as drug carriers for treatment of psychiatric disorders without compromising neurogenesis and neurodevelopment
Click the green button above to contact Expert for a free initial screening call regarding expert testimony, litigation consulting and support, forensic services, or any related expert witness services.  A few litigation needs include product liability, personal injury, economic loss, intellectual property (patent, trademark, trade secret, copyright), and insurance matters.  Remember, your initial screening call to speak with Expert is free.

International Experience:
Years   Country / Region   Summary
2011 to 2012   Germany   He carried out consultations on manipulation of the interrelationship between complement system and clock genes in ADHD as a strategy for a therapy.
2012 to 2013   Kuwait   He consulted on biomarkers for the response to drug treatment of major depression. Further analyses on signalling/molecular mechanisms underlying responses in major depression and identification of suitable therapeutic targets for drug development were undertaken.
2010 to 2012   Bulgaria   He consulted on different nanoparticles designed as drug carriers in their applicability for treatment of psychiatric disorders without compromising neurogenesis and neurodevelopment.
2013 to 2013   Switzerland   He consulted on methods employed in pharmaceutical and cosmetic industries, and academic research for development of robotised testing platforms.
2006 to 2006   Russia   He consulted on satellite DNA binding drugs.

Language Skills:
Foreign Language   Description
English   He is fluent in English language
Bulgarian   He is fluent in Bulgarian language
Russian   He is fluent in speaking and reading, and intermediate in writing in Russian language

Market Research:
Expert's background and expertise suits perfectly pharmaceutical industries interested in development of therapeutics for treatment of neurodevelopmental and neurodegenerative disorders, and for cancer immunotherapy. He has also experience in consulting companies for development of robots for use in chemical, pharmaceutical and biotechnology industries and academic research. Running his own company in scientific publishing, antibody sales and development of skin care products, he has developed customer focused attitude with excellent communication, leadership and influencing skills. Being editor-in-chief of a scientific periodical, Expert considerably increased the reputation and sales of this journal.

Click the green button above to contact Expert for a free initial screening call regarding your marketing research, industry research, and company research needs.  For research needs involving multiple experts or secondary research, a Research Director can be assigned to coordinate the work into a custom report for you as a potentially quicker and more cost effective alternative to doing this work yourself or hiring a boutique consultancy.  Remember, your initial screening call to speak with Expert is free.

Additional Skills and Services:
Training/Seminars

Editor of a number of books, including Inflammation in Neuropsychiatric Disorders, Protein-Nucleic Acids Interactions, Organisation of Chromosomes, Protein Structure and Diseases.

Other Skills and Services

- research and advise on alterations in signalling pathways/metabolism in psychiatric, neurological disorders and tumours and ways of exploring these alterations for therapeutic benefit - design of processes for creation of robotised platforms for pharmaceutical and cosmetic industries, and academic research - applicability of drug carriers for treatment of developmental psychiatric disorders

TEAM LEADERSHIP  Proven ability to manage through others.  Strong decision making and problem solving skills  Able to motivate and lead others in a team environment


 

Need the right expert?  We can help!

home       find an expert       request an expert       join our network       about us

FOLLOW ORC ON